Black patients more likely to be excluded from pancreatic cancer

Bassel El-Rayes named deputy director of O'Neal Comprehensive Cancer Center - The Cancer Letter

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - ScienceDirect

AACI Update

C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT?, Cancer Imaging

SOM Discoveries 2022 VCU School of Medicine

Frontiers Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer

Foundation stirs controversy by charging cancer patients $83,000 for unproven but promising experimental drug - The Boston Globe

Bassel El-Rayes named deputy director of O'Neal Comprehensive Cancer Center - The Cancer Letter

Frontiers Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study

Issue 13 - The Cancer Letter

Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement

SOM Discoveries 2022 VCU School of Medicine